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982Bicuspid Aortic Valve: Inter-Racial Difference in
Frequency and Aortic Dimensions
O B J E C T I V E S The objective of this study was to examine the similarities and differences in
Caucasian (C) and African-American (AA) patients with bicuspid aortic valve (BAV) with respect to
morphology, severity of aortic stenosis/insufﬁciency, and aortic dilation.
B A C KG ROUND BAV is a common congenital valve abnormality, accounting for a large number of
alve replacements.
METHOD S A total of 229 patients with the diagnostic code BAV were identiﬁed retrospectively from
ur computerized adult echocardiographic database, which consists of 91,896 studies performed at the
niversity of Chicago Medical Center from 1998 to 2009, representing 40,878 patients. Of those, 183
atients with BAV were included in this retrospective BAV single-center cohort study and reanalyzed
ith a comprehensive assessment of aortic dimensions, aortic valve morphology and function, clinical
ardiovascular risk factors, and patient characteristics.
R E S U L T S Of the 183 patients with BAV, 138 were C and 45 were AA. Our echocardiographic
atabase encompasses approximately 65% AA, 31% C, and 4% other races, for an estimated frequency
f BAV in AA patients of 0.17% and a frequency in C patients of 1.1% (p  0.001). There were no
igniﬁcant inter-racial differences regarding sex, height, weight, hyperlipidemia, diabetes, tobacco use,
ardiac medications, and left ventricular ejection fraction. The AA cohort was older (age 50  17 years vs.
43 17 years, p 0.05) and had a higher prevalence of hypertension (51% vs. 24%, p 0.05). After adjusting
for comorbidities, aortic dimensions were larger in C (C vs. AA: annulus, 2.4  0.4 vs. 2.1  0.4 cm; sinuses
of Valsalva, 3.4 0.7 vs. 3.1 0.6 cm; sinotubular junction, 3.0 0.6 vs. 2.6 0.5 cm; and ascending aorta,
.5  0.7 vs. 3.2  0.5 cm; all p values 0.05).
CONC L U S I O N S This is the ﬁrst study to report racial differences among patients with BAV with
educed aortic dimensions in AA patients despite the presence of more risk factors, suggestive of marked
eterogeneity in the BAV population and indicating race as a potential disease modiﬁer in BAV. (J Amoll Cardiol Img 2012;5:981–9) © 2012 by the American College of Cardiology Foundation
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picuspid aortic valve (BAV) is a common
congenital heart valve abnormality, account-
ing for a large number of valve replacements
in the United States. Although still incom-
letely understood, the natural history of BAV
isease often results in severe aortic stenosis or
nsufficiency and is associated with ascending aortic
ilation. The population frequency of BAV has
een reported at 0.5% to 1.36%, commonly stated
s 1% to 2% (1–3). BAV has a high heritability with
predilection for males of 3:1, supporting the
revious recommendation to screen first-degree rel-
tives of patients with BAV (4). Patients with BAV
ompared with those with trileaflet aortic valves
ave larger aortic root dimensions and increased
isk of ascending aortic dilation during their life- Wime. The aortopathy and increased susceptibility to
alvular stenosis and regurgitation place the patient,
specially in adulthood, at higher risk of surgical
ntervention (5,6). Although there is an increased
robability of aortic dilation and/or dissection in
AV patients, the optimal way to assess and char-
cterize patients at risk has been a subject of debate
n the medical literature. Most previously reported
AV studies included nonracially diverse popula-
ions, primarily Caucasian (C) and to a much lesser
xtent African American (AA). To our knowledge,
here are no studies specifically addressing potential
acial differences in BAV disease, which could yield
mportant insight into genetic contributions to
revalence and disease phenotype in BAV disease.e, therefore, sought to characterize similarities
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983and differences in C and AA patients with BAV
with respect to: 1) overall BAV frequency; 2) type
of BAV morphology; 3) presence of aortic stenosis/
insufficiency; and 4) aortic dilation.
M E T H O D S
We retrospectively reviewed 229 patients with an
echocardiographic diagnosis of BAV who under-
went clinically indicated transthoracic studies from
1998 to 2009 at the University of Chicago. The
University of Chicago Medical Center is the main
tertiary referral center for the south side of Chicago,
serving a predominantly AA population. We used
BAV as a diagnosis code to query our computerized
echocardiographic database, which consists of
91,896 transthoracic studies performed during the
stated time span. Of these, 73,667 studies were
complete transthoracic studies representing 40,878
individual patients. The inclusion criteria were doc-
umentation of BAV on transthoracic echocardiog-
raphy. Of the 229 patients with diagnosed BAV, we
excluded 46 patients because of race other than C or
AA (4 Hispanic and 3 Asian patients), supravalvu-
lar or subvalvular stenosis, the presence of other
complex congenital cardiac defects (5 C patients, 2
AA patients), Marfan syndrome (1 C patient),
incomplete medical record data and/or poor visual-
ization of aortic valve or ascending aorta (n  24),
and lack of confirmation of bicuspid status by 2
independent echocardiographers (5 C patients, 2
AA patients). Accordingly, 183 patients were in-
cluded in the final analysis; of these, 138 were C
and 45 were AA (Fig. 1).
Echocardiographic data. All echocardiographic stud-
ies were performed using the same commercially
available equipment in a single adult cardiac imag-
ing center, accredited by the Institutional Commis-
sion for the Accreditation of Echocardiography
Laboratories. Initially, the echocardiographic stud-
ies of all 229 patients with diagnosis code BAV
were used for the purpose of this retrospective study
and reanalyzed by 2 independent and trained ob-
servers. A third observer (R.M.L.) blinded to pre-
viously performed analyses resolved any discrepan-
cies. Aortic valve morphology was identified in
multiple parasternal short-axis views and transtho-
racic echocardiographic studies when available and
classified as type 1 (congenital fusion of right and
left coronary cusp resulting in an anteroposteri-
orly oriented bileaflet morphology); type 2 (con-
genital fusion of the right and noncoronary cusp
resulting in right-left oriented bileaflet morphol-ogy); and type 3 (congenital fusion of the non-
coronary and left coronary cusps) using a pheno-
typic classification of leaflet morphology (7). The
presence or absence of a raphe was noted, but not
used in the final analysis. Using the leading-edge
technique, aortic diameters were prospectively
measured at end-diastole in the parasternal view
perpendicular to the long axis at several locations,
including the annulus, sinuses of Valsalva, sino-
tubular junction (STJ), and, when possible, at
least 2 cm distal from the STJ in the ascending
aorta or the largest of multiple measurements
performed above the STJ (8).
Echocardiography board–certified cardiologists
read all echocardiograms. The severity of aortic
valve stenosis, aortic regurgitation, and left ventric-
ular ejection fraction was defined according to
practice guidelines (9,10).
Covariate measurements and deﬁnitions. For each
atient, medically pertinent data were obtained
rom medical records; outpatient clinic visits; and
n-patient hospitalization including age, sex, U.S.
ip codes of the home address, height, and
eight (at the time of the echocardio-
raphic study), the presence of vascular
isk factors including hypertension, dyslip-
demia, diabetes, and smoking history; and
edication use. Hypertension was defined
y Joint National Committee VII guide-
ines (systolic blood pressure of 140 mm
g, diastolic blood pressure of 90 mm
g, or reported use of antihypertensive medications
ithin 6 months before or after the echocardio-
raphic evaluation). Body mass index was calculated
s weight divided by height squared (kg/m2). Body
surface area was calculated as height (inches) times
weight (pounds) divided by 3,131 (square meters).
The race of the 229 patients with BAV was classi-
fied as AA, C, Hispanic, or Asian based on infor-
mation available to us either from the physician
order entry for the echocardiographic study or
available in the physician’s note. In the case of no
available data on race in the BAV patients, we
prospectively performed telephone interviews to
obtain this information. Of the 40,878 patients who
were initially screened for the diagnostic code BAV,
we had information regarding physician-determined
race for 18,475 patients, representing 45.2% of the
study cohort. Of these, 65% were AA, 31% were C,
and 4% were of other races. We estimated that of
the 40,878 patients whom we studied, approxi-
mately 26,570 were AA, 12,672 were C, and 1,635
A B B
A N D
AA
BAV
C C
STJwere of other races. The study protocol wR E V I A T I O N S
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984proved by the institutional review board, including
access to health records, imaging data, and tele-
phone contact with patients (for which verbal con-
sent was obtained).
Statistical analysis. Data are presented for each race
eparately and expressed as mean  SD for contin-
ous variables and as percentages for categorical
ariables. An independent Wilcoxon test was used
or continuous variables, and the Fisher exact test
as performed to analyze different outcomes in
ategorical variables. The Spearman rank correla-
ion was used for calculation of intraobserver and
nterobserver variability.
Multivariate linear regression analyses for the
ndpoint of aortic dimension were conducted to
etermine which clinical and echocardiographic
ariables were significantly associated with aortic
imensions. We tested age, sex, hypertension sta-
us, body surface area, left ventricular ejection frac-
ion (abnormal defined as an ejection fraction
50%), aortic valve hemodynamics, and the use of
edications as covariates in this multivariate linear
egression model.
Intraobserver variability of the aortic measure-
ents was assessed using repeated measurements
m 1998-2009
 studies
lete TTE studies
nts
65%)
1%)
races (4%)
de “BAV”
 TTE, 73 TEE)
Exclusion:
False diagnosis of BAV excluded after 
review (n = 7)
Non-inclusion:
• Non-African American, non-Caucasian
  (n = 4 hispanic and 3 asian patients) 
• Complex congenital heart disease (n = 8)
  Incomplete Data (n = 24) 
th BAV included 
Caucasian
    n = 138
n
with bicuspid aortic valve (BAV) were screened, and 183 African-
asian (C) patients with BAV were included. TEE  transesophageal
 transthoracic echocardiography.erformed by the same observer on 50 patients Mrandomly selected 30 C and 20 AA patients) 2
onths later. Interobserver variability was evalu-
ted by repeating the analysis on 50 patients
previously randomly selected 30 C and 20 AA
atients) by a second independent observer
linded to the results of all previous measure-
ents. Variability was defined as the absolute
ifference between repeated measurements ex-
ressed as a percentage of their mean.
R E S U L T S
Clinical characteristics. Our final study population
consisted of 183 patients (126 males, 57 females)
with BAV. The patients with BAV were divided
into 2 groups according to their race; of these, 138
(77%) patients were C and 45 (25%) were AA.
The mean age of these patients was 45 years
(C: 43  17 years vs. AA: 50  17 years; p  0.03).
The baseline characteristics are shown in Table 1.
There were no significant inter-racial differences
regarding sex; height; weight; hyperlipidemia; dia-
betes; tobacco use; cardiac medications including
beta-blockers, angiotensin receptor blockers, and
angiotensin-converting enzyme inhibitors; left ven-
tricular cavity dimensions; and left ventricular ejec-
tion fraction. Therapy with diuretics was signifi-
cantly higher in the AA group (AA: 34% vs. C:
19%; p  0.05). The AA group was not only
significantly older, but also had a higher prevalence
of hypertension (AA: 49% vs. C: 24%; p  0.001)
with more frequent use of diuretic medications.
Frequency of BAV in our cohort. We found 229
atients with BAV in our cohort of 40,878 patients
ith an estimated prevalence of 0.56%. After re-
iewing all patients, we excluded 7 patients because
ither expert review or additional available trans-
sophageal echocardiographic images showed a
rileaflet valve. We did not include BAV patients
ith: 1) complex congenital heart disease (n  8);
) race other than AA or C (n 7); and 3) patients
ith incomplete datasets (n  24), thereby arriving
t the number of 183 well-characterized patients
ith BAV (Fig. 1). Interestingly, we found fewer
atients with BAV among AAs; with 45 having
AV out of 26,570 screened AA patients repre-
ented in our echocardiography database. In con-
rast, 138 C patients with BAV were identified
rom 12,672 C patients represented in our echo-
ardiography database. From our cohort, we calcu-
ated the prevalence of BAV for AA individuals to
e 0.17% and 1.1% for C individuals (p  0.001).ECHO database fro
     n = 91.896 echo
     n = 73.667 comp
     n = 40.878 patie
         ~ 26,570 AA (
         ~12,672 C   (3
         ~1,635 other 
Diagnosis co
n = 375 echos (302
n = 229 patients
n = 183 patients wi
African American
          n = 45
Figure 1. Study Desig
A total of 229 patients
American (AA) or Caucore than 90% of C and AA individuals with BAV
amet
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985lived within 15 miles of the Medical Center based
on their zip code, suggesting that this cohort
reflects an urban population without specific referral
pattern. There was no racial difference in the BAV
morphology between AA and C patients. Both
races had predominantly type 1 BAV (AA: 71%,
C: 82%; p  0.71) and less often type 2 BAV (AA:
29%, C: 18%, p  0.68). Type 3 morphology was
only found in 1 C patient (Table 1).
Interestingly, our data showed a trend toward an
increased prevalence of functionally normal bicus-
pid valves in AAs (i.e., lacking any discernible aortic
valve stenosis or insufficiency compared with C
individuals); however, this finding did not reach
statistical significance (AA: 44% vs. C: 29%, p 
0.067). Moreover, there was no statistically signif-
icant difference in the prevalence of mild to severe
bicuspid valve stenosis or insufficiency between
races (Table 1). Five percent of AA patients had
Table 1. Baseline Characteristics of the 183 Patients With BAV
All Patients (N  183)
Male* 126 (69.0)
Age, yrs† 44.8 (17.0)
Height, inches† 69.4 (4.8)
Weight, lbs† 177.9 (41.1)
Hypertension* 55 (30.0)
Hyperlipidemia* 32 (18.0)
Beta-blocker* 39 (21)
ACEI/ARB* 41 (22)
Type of BAV*
1 145 (79)
2 37 (20)
3 1 (1)
Aortic stenosis*
None 133 (73)
Mild 24 (13)
Moderate 14 (7)
Severe 11 (6)
Aortic insufﬁciency*
None 86 (47)
Mild 74 (41)
Moderate 15 (8)
Severe 7 (4)
No AS and AI* 57 (32)
Coarctation, % 9 (5)
Mean LVEDD, cm† 4.9 (0.8)
Mean LVESD, cm† 3.2 (0.5)
*For categorical variables, the values shown are n (%). The Fisher exact test wa
AA and C were compared by independent Wilcoxon test.
AA  African American; ACEI  angiotensin-converting enzyme; AI  aort
bicuspid aortic valve; C  Caucasian; LVEDD  left ventricular end-diastolic disevere aortic stenosis and 4% had severe aorticinsufficiency compared with 7% and 4% in C
patients, respectively (p  0.05).
Aortic dimensions. Both intraobserver and interob-
server variability in the measurement of aortic
dimensions at any site was minimal. The squared
correlation coefficients (R2) for intraobserver and
interobserver variability ranged from 0.91 to 0.97
and 0.87 to 0.93, respectively. Most interestingly,
there were significant differences in the aortic di-
mensions between groups (Table 2). The linear
dimensions of the aortic annulus, sinuses of Val-
salva, STJ, and ascending aorta were significantly
larger in C compared with the AA patients, before
and after adjusting for age, sex, hypertension, body
surface area, the presence of moderate to severe
aortic stenosis or insufficiency, and medication use
including beta-blockers, angiotensin-converting
enzyme inhibitors, and angiotensin receptor block-
ers. The largest difference in diameter occurred at
AA (n  45) C (n  138) p Value
29 (64.0) 97 (70.8) 0.4
49.9 (17.1) 43.2 (16.8) 0.03
68.9 (5.7) 69.6 (4.5) 0.6
183.9 (54.5) 176.1 (36.3) 0.5
22 (49.0) 33 (24.1) 0.001
8 (18.0) 24 (17.6) 0.8
12 (27) 30 (22) 0.3
12 (29) 32 (23) 0.3
0.11
32 (71) 113 (82)
13 (29) 24 (17)
0 (0) 1 (1)
0.72
34 (76) 99 (72)
5 (11) 20 (14)
4 (9) 10 (7)
2 (5) 9 (7)
0.48
25 (56) 61 (45)
15 (33) 59 (43)
3 (7) 12 (9)
2 (4) 5 (4)
18 (44) 39 (29) 0.07
2 (5) 7 (5) 0.95
4.8 (0.8) 4.9 (0.7) 0.46
3.2 (0.4) 3.4 (0.5) 0.88
ed to compare AA and C. †Continuous variables are shown as mean (SD), and
sufﬁciency; ARB  angiotensin receptor blocker; AS  aortic stenosis; BAV 
er; LVESD  left ventricular end-systolic diameter.s us
ic inthe STJ level (Fig. 2).
conﬁdence interval.
n Tab
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986D I S C U S S I O N
Our study is the first to examine racial differences in
patients with BAV in a retrospective cohort from
our hospital that represents a large number of AA
and C patients undergoing clinically indicated
transthoracic echocardiography. Because of sug-
gested strong genetic factors contributing to BAV
and the possibility for progression of BAV-
associated complications, such as aortic valve re-
placement and thoracic aortic aneurysms, we sought
to specifically examine BAV disease characteristics
in a community cohort that included 2 different
races (i.e., AA and C).
Surprisingly, we found an overall lower than
reported frequency of BAV in our cohort (0.45%) of
40,878 patients with an even smaller frequency
among AA patients (0.17%) compared with 1.1% in
C patients. Although this is an intriguing finding
suggesting a possible lower prevalence of BAV in
0 -0.25 0
African American Patients
With BAV
Caucasian Patients
With BAV
Difference in Aortic Size (cm)
With BAV Have Smaller Aortic Dimensions
aortic dimensions between African-American (AA) compared
s with bicuspid aortic valve (BAV) after adjustment for age, sex,
e to severe aortic valve stenosis/insufﬁciency, use of beta-block-
rting enzyme inhibitors, or angiotensin receptor blockers demon-
imensions in AA patients. Data are shown as mean and as 95%
Table 2. Aortic Measurements
All Patients
(N  183)
AA
(n  45)
C
(n  138)
Annulus, cm 2.3 0.4 2.1 0.4 2.4 0.4
Sinus, cm 3.3 0.6 3.1 0.6 3.4 0.7
STJ, cm 2.8 0.6 2.6 0.5 3.0 0.6
Ascending aorta, cm 3.4 0.7 3.2 0.5 3.5 0.7
Mean  SD and 95% conﬁdence interval were compared between AA and
unadjusted measurements. *Adjusted for age, sex, hypertension, moderate to se
enzyme inhibitors or angiotensin receptor blockers, and shows signiﬁcant sma
CI  conﬁdence interval; STJ  sinotubular junction; other abbreviations as iAA individuals, the retrospective design of our
study using a selected cohort of patients undergoing
a clinically indicated echocardiographic study pre-
cludes such a conclusion. Only a random sample of
the entire population could determine the true
prevalence of BAV. There is limited information on
the prevalence of BAV in AA individuals in the
literature, although it was previously reported in a
comment as being lower than other populations
(11). Moreover, AAs with BAV trended toward a
higher prevalence of preserved aortic valve function
despite being 6 years older and having a higher
prevalence of hypertension and a similar predomi-
nance of type 1 BAV, as previously reported in
other cohorts of BAV (7). This suggests that AA
patients could possibly have a milder phenotype of
BAV dysfunction consistent with our findings of
less aortic dilation in this group. It has been
reported that patients with BAV compared with
trileaflet aortic valve have larger aortic dimensions,
an increased rate of dilation, and possibly a higher
risk of dissection, although the actual reported rate
is low, at approximately 2% to 4% (12,13). There
exists considerable variability and uncertainty on the
extent of, definition of, and susceptibility to
dilation. Moreover, aortic dilation prevalence es-
timations vary depending on the study population
and the specific region of the aorta measured
(5,12,14,15).
There is substantial support for genetic factors
and for developmental mechanisms related to the
shared derivation of the aortic valvular cusps and
aortic medial layer from the neural crest cells (16) as
well contributing factors related to hemodynamic
stress exerted on the aortic wall by the eccentric
turbulent flow across the bicuspid valve (17) that
collectively contribute to the development of tho-
racic aortic aneurysms. In our study cohort, the
increased aortic dilation in C compared with AA
patients despite a similar prevalence in BAV mor-
Unadjusted Analysis Adjusted Analysis*
ifference (95% CI) p Value Difference (95% CI) p Value
0.28 (0.13 to 0.43) 0.001 0.27 (0.12 to 0.43) 0.0001
0.23 (0.01 to 0.41) 0.04 0.27 (0.03 to 0.45) 0.02
0.31 (0.12 to 0.51) 0.001 0.36 (0.15 to 0.56) 0.0001
0.25 (0.04 to 0.47) 0.04 0.29 (0.02 to 0.55) 0.03
tients with bicuspid aortic valve by multivariate linear regression analysis as
aortic stenosis/insufﬁciency, and use of beta-blocker or angiotensin-converting
ortic dimension in AA patients with bicuspid aortic valve.
le 1.Ascending Aorta
STJ
Sinus of Valsalva
Annulus
-0.5
Figure 2. AA Patients
Absolute differences in
with Caucasian patient
hypertension, moderat
ers, angiotensin-conve
strated smaller aortic dD
C pa
vere
ller aphology and regurgitant or stenosis severity raises
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987some important issues regarding the role of genetic
or other vascular modifiers. In this context, it is
interesting to note that the MESA (Multi-Ethnic
Study of Atherosclerosis) found racial differences in
aortic physiology among the 1,053 participants
without overt clinical cardiovascular disease (and
presumably trileaflet aortic valve) demonstrating
reduced aortic distensibility and increased aortic
stiffness in AA patients. Other risk factors for aortic
stiffness in this study included older age, smoking,
and hypertension (18). It is possible that intrinsic
factors within the aortic wall, such as increased
fibrosis or cross-linking of extracellular matrix,
could be mediating the reduced aortic distensibility,
leading to increased aortic stiffness and potentially
the prevention of aortic dilation in AAs. Indeed,
vascular mechanical studies performed on healthy
young males post-exertion and in hypertensive,
nonmedicated AA individuals compared with their
C counterparts have demonstrated greater aortic
stiffness, augmentation index, and reduced wave
reflection travel time (19,20). Indexes of aortic
stiffness in BAV patients have been found to be
abnormal in those with a dilated proximal ascend-
ing aorta compared with those with BAV without a
dilated ascending aorta (21,22). Interestingly, these
abnormal load-bearing characteristics of the aorta
persist in BAV patients despite making adjustments
for vessel dimension and differences in blood pres-
sure (23). There is considerable variability in these
parameters in the literature, and it is yet to be
established whether aortic stiffness or elasticity dif-
fers among AA and C individuals with BAV.
Among all the risk factors, including significant
valve disease, age is considered the most important
variable associated with dilation of the ascending
aorta (24). Despite the older age, the higher inci-
dence of hypertension in our study, and similar
prevalence of beta-blocker, angiotensin receptor
blocker, or angiotensin-converting enzyme inhibi-
tor use, the AA group had comparably smaller
aortas, supporting the hypothesis of a genetic sus-
ceptibility for aortic remodeling.
Currently, thoracic aortic diameter and its pro-
gression rate serve as the main criteria for risk
stratification in BAV patients with or at risk of
aortic dilation and/or dissection, but they do not
serve as prerequisites for dissection. It is estimated
that in 6% of patients with BAV, a type A thoracic
aortic dissection develops, or, conversely, BAV is
found in 2% to 9% of patients with this type of
dissection (13,25,26). Studies stemming from the
International Registry of Aortic Dissection havenoted that aortic dissections occur at aortic diame-
ters 5.0 cm, the recommended threshold for
elective ascending aortic replacement, although the
percentage of dissection is small (27–29). Studies
from Toronto and Olmstead County of BAV pa-
tients indicate a low acute event rate, with inter-
ventions consisting mostly of surgical procedures
involving the aortic valve and aortic root replace-
ments in an older population (13,30). It is not
entirely clear whether dissection rates in these
studies were derived from a BAV population that
was racially heterogeneous.
Indicative of the low representation of the minority
patient populations in these studies is the National
Heart, Lung, and Blood Institute–funded GenTAC
(National Registry of Genetically Triggered Thoracic
Aortic Conditions), which is a very promising start in
assessing genetic predisposition to thoracic aortic an-
eurysms and dissection and is especially interested in
recruiting minorities (31). The Registry reported that
despite representation of clinical centers with large
black populations, only 8.9% of the subjects enrolled
were a self-identified minority, of whom 6.6% were of
Hispanic origin. There exists significant variation in
genetic and racial origins and susceptibilities to dila-
tion or dissection in the literature. The reported
figures may not account for individuals with thoracic
aortic dissection who die undiagnosed outside of
hospital settings and without an autopsy. A com-
parison of the clinical profile between the Interna-
tional Registry of Aortic Dissection population (4%
minorities) and autopsy-based study of out-of-
hospital deaths from aortic dissection among the
more ethnically diverse residents (48%) of Harris
County, Texas, yielded interesting findings (32,33).
Compared with the International Registry of Aortic
Dissection, autopsy results from this study demon-
strated that patients with type A aortic dissection
were likely to be Hispanic and of younger average
age (42 years and 43 years in those with congenital
heart disease) and have a higher prevalence of BAV.
Our study emphasizes the need to include minori-
ties in BAV-related outcomes studies to fully un-
derstand and develop risk-stratification and surveil-
lance tools that may better serve this patient
population.
Study limitations. One of the limitations is the
retrospective nature of this study that resulted in
exclusion of BAV patients due to incomplete clin-
ical dataset. Another limitation is the possibility of
underestimation of BAV because we did not review
the images of all other echocardiographic studies in
our computerized databank that were not classified
m
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988as BAV during the initial evaluation by an echocar-
diography board–certified reader. Moreover, BAV
could have been missed in cases of heavily calcified
aortic valve disease with severe aortic stenosis.
There is a possibility that echocardiography under-
estimated or missed the presence of BAV and the
eccentric remodeling patterns in the ascending
aorta that were beyond the imaging capabilities of
this 2-dimensional modality. Until cardiac mag-
netic resonance imaging becomes more accessible,
transthoracic echocardiography remains the main-
stay for screening and interval surveillance of these
patients, although full periodic aortic surveillance is
warranted in these patients (29). The prevalence of
aortic valve dysfunction or aortic enlargement in our
study may be different from others. Moreover, our
study was a single-center, retrospective study and
therefore was limited with regard to samples size.
Future studies are needed to confirm our findings of
race as a modifier for BAV disease. We cannot
exclude the possibility of referral bias, and theintegrated phenotypic classification
1
valvular regurgitato medical care may have influenced our study
results; however, the zip code analysis of our patient
population confirms that it is indeed representative
of the south side of Chicago.
C O N C L U S I O N S
Our finding of a lower frequency of BAV and
reduced aortic dimensions despite an increased
presence of risk factors (i.e., systemic hypertension
and older age in AAs in our retrospective cohort
study) calls for further prospective, outcomes-based
studies in this minority population to individualize
risk stratification and therapy accordingly.
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